Loading clinical trials...

Virtual Reality (VR) Self-Hypnosis Software | Clinical Trials | Clareo Health

RECRUITINGNA

Virtual Reality (VR) Self-Hypnosis Software

An Open-label Study of Self-hypnosis Software for Virtual Reality for the Treatment of HIV-associated Chronic Pain - a Development and Usability Study

NCT06398847•Icahn School of Medicine at Mount Sinai

View on ClinicalTrials.gov

Summary

This single-site study of self-hypnosis software using an off-the-shelf virtual reality (VR) device (OculusGo™) to determine the software's safety, usability, and preliminary efficacy in pain relief for HIV-associated chronic pain patients. This is funded under the i Prism Funding through Mount Sinai Innovations.

Detailed Description

The study will be done in two phases - Phase A is the development of the software by the study team and the engineers targeted to be completed by 4/15/2024. Testing will occur with only the study team. No participants will be involved in the testing phase. Phase B is the participant enrollment phase targeted to start 5/20/2024. A request for FDA Exemption of a non-significant risk combination device has been submitted and granted.

Eligibility

Age

18 - No limit years

Sex

ALL

Healthy Volunteers

Inclusion Criteria

•Patient Eligibility
•Adults age ≥18
•Confirmed diagnosis of HIV, currently on a stable antiretroviral regimen ≥ 90 days.
•Documentation of chronic pain associated with HIV for≥90 days
•Stable pain management regimen ≥90 days, or no pain treatments ≥90 days
•Average pain intensity of 3 or greater on the NRS of the mean daily scores reported between Visit 1 and Visit 2
•Access to the internet via smartphone, computer, or tablet 7. Fluent in English
•Capable of giving informed consent and willingness to comply with study procedures.

Exclusion Criteria

•A co-occurring medical or psychiatric condition which would make participation in the study or complicate measurement of changes associated with the intervention.
•Concurrent participation in another investigational protocol for pain treatment
•A psychiatric disorder, medical condition, or other life circumstance, which in the opinion of the PI, would contraindicate attendance at sessions, or make it unlikely that the participant could successfully complete the study procedures.
•Current or prior diagnosis of epilepsy, seizure disorder, dementia, migraines, or other neurological conditions contraindicating the use of virtual reality devices.
•A medical condition predisposing prospective participant to nausea or dizziness 6. Lack of stereoscopic vision or severe hearing impairment
•Injury to eyes, face, or neck that impedes using the VR device
•If participant has access to personal VR gear for gaming or other purposes at home, participant fails to agree not to use these personal VR gear during the course of the protocol.
•Currently pregnant or planning to become pregnant during the study period

Locations (1)

Icahn School of Medicine at Mount Sinai

New York, New York, United States

Key Dates

Start Date

January 31, 2026

Primary Completion Date

June 30, 2026

Completion Date

June 30, 2026

Last Updated

December 9, 2025

Enrollment

ESTIMATED participants

Conditions

Musculoskeletal PainNeuropathic PainNeuralgia

Interventions

Virtual Reality headset

DEVICE

Contacts

Mary Catherine George, PhD

CONTACT

646-808-6231 mary-catherine.george@mssm.edu

SPS Block vs. Surgical Intercostal Block for Chronic Pain After Thoracoscopic Surgery

NCT07436806

Chronic Post-thoracotomy PainNeuropathic Pain+1 more

View study

RECRUITINGNA

Repetitive Transcranial Magnetic Stimulation Therapy in Spinal Cord Injury Related Neuropathic Pain

NCT06726954

Spinal Cord InjuriesNeuropathic Pain

View study

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: December 9, 2025Data synced to Clareo: March 29, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions

Virtual Reality (VR) Self-Hypnosis Software

Inclusion Criteria

Exclusion Criteria

SPS Block vs. Surgical Intercostal Block for Chronic Pain After Thoracoscopic Surgery

Repetitive Transcranial Magnetic Stimulation Therapy in Spinal Cord Injury Related Neuropathic Pain

Neuropathic Characteristics of Subacromial Pain Syndrome

A Chronic Pain Master Protocol (CPMP): A Study of LY4065967 in Participants With Diabetic Peripheral Neuropathic Pain

Effect of TMS on Neuropathic Pain for Patients With Sci

Severe Chronic Neuropathic Pain: A Treatment Bundle, Using Spinal Cord Stimulation and Multidisciplinary Treatment, to Reduce Pain and Improve Physical Function.